- Trade $0 commission stocks & ETFs with as little as $1
- Earn up to $300 with qualifying deposits
- Discover new opportunities with Opto's AI-driven thematic investing system
- Theme and ETF screener
Accolade Inc is a health information services business based in the US. Accolade Inc shares (ACCD) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $3.49 – a decrease of 5.16% over the previous week. Accolade Inc employs 2,400 staff and has a trailing 12-month revenue of around $441 million.
Our top picks for where to buy Accolade Inc stock
- Trade $0 commission stocks, ETFs, and options with as little as $1
- After-hours trading available
- Earn 4.5% interest on uninvested cash with Gold
- 24/7 customer support
- $0 commission trading
- Instant withdrawals with a 1.75% fee
- Supports 250+ cryptocurrencies
- High-yield account earns up to 4.65% APY
Disclaimer: This page is not financial advice or an endorsement of digital assets, providers or services. Digital assets are volatile and risky, and past performance is no guarantee of future results. Potential regulations or policies can affect their availability and services provided. Talk with a financial professional before making a decision. Finder or the author may own cryptocurrency discussed on this page.
How to buy Accolade Inc stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – ACCD. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Accolade Inc stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Accolade Inc stock price (NASDAQ: ACCD)
Use our graph to track the performance of ACCD stocks over time.Accolade Inc shares at a glance
Latest market close | $3.49 |
---|---|
52-week range | $3.08 - $15.36 |
50-day moving average | $3.72 |
200-day moving average | $6.43 |
Wall St. target price | $7.08 |
PE ratio | N/A |
Dividend yield | N/A |
Earnings per share (TTM) | $-1.02 |
Is it a good time to buy Accolade Inc stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Accolade Inc price performance over time
Historical closes compared with the close of $3.38 from 2024-11-18
1 week (2024-11-14) | -6.11% |
---|---|
1 month (2024-10-18) | -3.43% |
3 months (2024-08-19) | -20.84% |
6 months (2024-05-17) | -54.81% |
1 year (2023-11-17) | -58.06% |
---|---|
2 years (2022-11-18) | -59.38% |
3 years (2021-11-19) | 30.73 |
5 years (2019-11-17) | N/A |
Accolade Inc financials
Revenue TTM | $441 million |
---|---|
Gross profit TTM | $165.3 million |
Return on assets TTM | -7.27% |
Return on equity TTM | -18.61% |
Profit margin | -18.16% |
Book value | $5.26 |
Market Capitalization | $289.9 million |
TTM: trailing 12 months
Accolade Inc share dividends
We're not expecting Accolade Inc to pay a dividend over the next 12 months.
Accolade Inc share price volatility
Over the last 12 months, Accolade Inc's shares have ranged in value from as little as $3.08 up to $15.36. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Accolade Inc's is 2.016. This would suggest that Accolade Inc's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Accolade Inc overview
Accolade, Inc. , together with its subsidiaries, engages in the development and provision of personalized and technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based intelligent technology and multimodal support from a team of advocates and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women's health specialists, case management specialists, expert medical opinion providers, and primary care physicians. It also provides medical opinion services to commercial customers; and navigation, care, and advocacy solutions. In addition, the company offers medical consultations that connect patients to qualified condition-specific specialists for adult and pediatric care; and primary care and mental health support solutions. It serves employers who provide employees and their families a single place to turn for their health, healthcare, and benefits needs. The company was incorporated in 2007 and is headquartered in Seattle, Washington.
Frequently asked questions
nullWhat percentage of Accolade Inc is owned by insiders or institutions?
Currently 3.074% of Accolade Inc shares are held by insiders and 79.655% by institutions. How many people work for Accolade Inc?
Latest data suggests 2,400 work at Accolade Inc. When does the fiscal year end for Accolade Inc?
Accolade Inc's fiscal year ends in February. Where is Accolade Inc based?
Accolade Inc's address is: 1201 Third Avenue, Seattle, WA, United States, 98101 What is Accolade Inc's ISIN number?
Accolade Inc's international securities identification number is: US00437E1029 What is Accolade Inc's CUSIP number?
Accolade Inc's Committee on Uniform Securities Identification Procedures number is: M01690102
More guides on Finder
-
Robinhood Now Let’s You Trade on the Outcome of the Presidential Election; Joining Kalshi and others.
Robinhood Launches Presidential Election Event Contracts Ahead of the Nov 5 Presidential Election
-
Today’s Best Brokerage Account Bonuses [Signup and Transfer Promos]
Explore the best bonuses for opening a new brokerage account.
-
Trading for Beginners: 9 Best Trading Platforms to Get Started
These are the best trading platforms for beginners, according to Finder’s comprehensive analysis.
-
SoFi Invest vs. Robinhood
Compare pros, cons, research tools and reviews for these two trading platforms.
-
10 Best Stock Apps of 2024 to Elevate Your Mobile Trading
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
-
10 Best Brokerage Accounts for Trading and Investing in 2024
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
How to Invest $10K
Maximize $10,000 with broker bonuses, IRA contribution matches, index funds, stocks, ladder CDs, hiring a financial advisor and more.
-
How to Invest $20K: 8 Ways to Maximize Earnings
Top ways to invest $20K include stocks, retirement accounts, conservative investments, ETFs and more. See our full list here.
-
Robinhood Review 2024: IRA Match and No Commissions
A deep dive into the highlights and limitations of Robinhood.
Ask a question